Belantamab Mafodotin,Pomalidomide,Dexamethasone
GSK
['belantamab', 'belantamab,mafodotin', 'multiplemyeloma']
despite evidence of durability, belantamab mafodotin misses endpoint for #multiplemyeloma provides perspective. #asco23
Official account of The Tisch Cancer Institute @MountSinaiNYC. Committed to cancer prevention, detection, treatment & research. Appointments:  1-844-MD CANCER